We focus on a number of topic areas identified by state health policy leaders as important to population health.
Keep up with news and updates from the Milbank Memorial Fund. Get the latest from thought leaders, including Christopher F. Koller, president of the Fund.
We publish The Milbank Quarterly, as well as reports, issues briefs, and case studies on topics important to population health.
The Center for Evidence-based Policy at Oregon Health & Science University is a national leader in evidence-based decision making and policy design.
The Milbank Memorial Fund is an endowed operating foundation that publishes The Milbank Quarterly, commissions projects, and convenes state health policy decision makers on issues they identify as important to population health.
News and Updates
September 21, 2016
The Center for Evidence-based Policy (CEbP) is making progress on SMART-D, the State Medicaid Alternative Reimbursement and Purchasing Test for High-Cost Drugs. Earlier this month, the SMART-D group released a report examining the landscape of Medicaid drug purchasing, specifically focusing on state Medicaid programs’ ability to pursue alternative payment models. The SMART-D Summary Report suggests that multiple opportunities exist to help improve patient access to evidence-based therapies while allowing states to predict and manage prescription drug costs. A new website, Smart-D.org, was also launched
“Today’s payment landscape is especially challenging for state Medicaid programs, which are struggling to balance budgets as more and more innovative treatments become available, often at a higher cost,” said Pam Curtis, director of CEbP. “This research can help achieve the triple win of maintaining access to treatments for Medicaid enrollees while also ensuring that drug manufacturers are reimbursed and states manage costs as effectively as possible.”
The Center is a strategic partner of the Milbank Memorial Fund (MMF); the two organizations collaborate on promoting the development of evidence-informed health policymaking capacity in states. MMF is assisting SMART-D with staff support, strategic counsel, and advisory-board convening. “Access to affordable prescription drugs is a key policy issue for states,” said Christopher F. Koller, president of MMF. “The SMART-D report is an authoritative overview of prescription drug programs in Medicaid and options for states to get more value for their enrollees.”
Now that Phase I of the project is complete, the SMART-D group plans to move forward with Phase II, which will involve working with several states to explore opportunities to collaborate with drug manufacturers and providing implementation and technical assistance to states.
The Milbank Memorial Fund is an endowed operating foundation that works to improve the health of populations by connecting leaders and decision makers with the best available evidence and experience.
A Better Way to Contain Medicaid Costs
June 13, 2019
Putting Primary Care First?
May 31, 2019
How New Data on Hospital Prices Paid by Employers Can Help States
May 29, 2019